Leelyn Smith’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Buy
34,849
+2,271
+7% +$183K 0.33% 83
2026
Q1
$2.82M Buy
32,578
+1,346
+4% +$129K 0.4% 71
2025
Q4
$3M Buy
31,232
+116
+0.4% +$11.3K 0.43% 62
2025
Q3
$2.96M Buy
31,116
+1,461
+5% +$134K 0.45% 60
2025
Q2
$2.59M Buy
29,655
+663
+2% +$56.2K 0.42% 64
2025
Q1
$2.61M Buy
28,992
+301
+1% +$26.9K 0.46% 62
2024
Q4
$2.29M Buy
28,691
+801
+3% +$69.3K 0.41% 73
2024
Q3
$2.51M Buy
27,890
+606
+2% +$51K 0.45% 64
2024
Q2
$2.15M Sell
27,284
-14,125
-34% -$1.16M 0.42% 67
2024
Q1
$3.61M Buy
41,409
+2,407
+6% +$205K 0.72% 37
2023
Q4
$3.21M Buy
39,002
+2,125
+6% +$162K 0.7% 39
2023
Q3
$2.89M Buy
36,877
+3,166
+9% +$265K 0.71% 40
2023
Q2
$2.97M Buy
33,711
+1,941
+6% +$167K 0.72% 36
2023
Q1
$2.56M Sell
31,770
-18,642
-37% -$1.52M 0.66% 47
2022
Q4
$2.14M Buy
50,412
+27,526
+120% +$2.23M 0.59% 57
2022
Q3
$1.85M Sell
22,886
-2,651
-10% -$238K 0.64% 50
2022
Q2
$2.29M Buy
25,537
+691
+3% +$70K 0.59% 47
2022
Q1
$2.76M Buy
24,846
+3,544
+17% +$374K 0.72% 39
2021
Q4
$2.2M Buy
21,302
+20,977
+6,454% +$2.43M 0.59% 46
2021
Q3
$41K Buy
325
+101
+45% +$13.1K 0.01% 204
2021
Q2
$28K Hold
224
0.01% 221
2021
Q1
$26K Hold
224
0.01% 228
2020
Q4
$26K Buy
224
+24
+12% +$2.64K 0.01% 222
2020
Q3
$21K Sell
200
-40
-17% -$4.02K 0.01% 224
2020
Q2
$22K Sell
240
-328
-58% -$31.5K 0.01% 262
2020
Q1
$51K Buy
568
+2
+0.4% +$213 0.03% 167
2019
Q4
$64 Buy
+566
New +$62.1K 0.03% 178

Other funds holding MDT

Leelyn Smith's MDT Position: Q2 2026 in Review

Leelyn Smith increased its Medtronic (MDT) stake by 7% in Q2 2026, buying an estimated $183K and bringing the position to 34,849 shares worth $2.73M. The position accounts for 0.33% of the portfolio, ranked #83.

Leelyn Smith first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.61M in Q1 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Leelyn Smith held 34,849 shares of Medtronic worth $2.73M as of Q2 2026.
  • Leelyn Smith bought 2,271 Medtronic shares in Q2 2026, an estimated $183K.
  • Medtronic made up 0.33% of Leelyn Smith's portfolio in Q2 2026, its #83 holding.
  • Leelyn Smith first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
  • Leelyn Smith's Medtronic position peaked at $3.61M in Q1 2024.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.